Omar Ishrak has his work cut out for him. Not only does he have to figure out a way to rejuvenate a business whose biggest division has slowed down and deal with regulatory pressures on the device ...

A U.S. Dept. of Justice probe into Medtronic Inc.’s (NYSE:MDT) marketing practices for its Infuse bone growth product line is growing, according to a report in the New York Times. The Old Grey Lady ...

In response to their prior inquiries, Medtronic Spine President Douglas King wrote letters to Minnesota Senators Al Franken and Amy Klobuchar, stating the adverse events that occurred during a study ...

NEW YORK (AP) — Medical device maker Medtronic Inc. has agreed to pay $85 million to resolve a federal class action lawsuit brought by a group of shareholders. In December 2008, the Minneapolis ...

(Reuters) - Medtronic Inc said it agreed to pay $85 million to settle a shareholder lawsuit accusing it of making misleading statements concerning Infuse, a genetically engineered bone graft used in ...

Medtronic appears to have been dealt a legal setback in its efforts to use a U.S. Supreme Court decision to protect itself against lawsuits related to its Infuse bone growth system.The Fridley, ...

U.S. Sen. Al Franken says Medtronic's handling of a study of its Infuse Bone Graft product may have "potentially skewed the risk profile" for thousands of patients and exposed "insufficient vigilance" ...